Glycosaminoglycans (GAGs) are some of the most relevant biological molecules, involved in important biological, physiological activities and also used as pharmaceutical agents. GAG research activities oriented to understand their nature, molecular population composition, characterisation, protein-GAG interaction network and putative pharmaceutical properties are essential to develop new drug with a more controlled and described activity. Recently experimental and clinical informations had increased the attention over heparan sulfate (HS)/ heparin (Hep) coagulant and not coagulant activity opening new fields of research oriented to develop new therapeutical strategy involving heparin usage. Hep mimetics/dericvatives can be extremely helpful from this perspective, due to their controlled nature, molecular features and structure, thus they can be employed as performance drugs. My Ph.D. thesis deals with statistical characterisation of commercial and not commercial pharmaceutical heparin, composition and structural characterisation of heparin mimetics and characterisation of protein-heparin interaction for drug design strategy. Thesis focus was oriented on three different subject: 1) build a library of accepted and well charaterised heparins, set up a statistical analysis based on a principal component analysis (PCA) approach to statistically define heparin molecular nature and to develop a new heparin quality control procedure. 2) 1D/2D NMR interaction studies (1H, TOCSY, NOESY, ROESY, trNOE and STD) to understand the importance of heparin antithrombin (AT) binding domain (AT-bd, the pentasaccharide β-D-N-acetylated,6-O-sulfated glucosamine -α(1->4)-D-glucuronic acid -β(1->4)-D-N-sulfated,3,6-O-sulfated glucosamine -α(1->4)-D-2-O-sulfated iduronic acid -α(1->4)-D-N-sulfated,6-O-sulfated glucosamine, also abbreviated as AGA*IA) flanking residues over AT activation on octasaccharides bearing the pentasaccharide sequence with normal or modified reducent residue in complex with AT. 3) dynamic light scattering (DLS) studies on amyloid beta 1-40 (Aβ1-40)-heparin or heparin mimetics/derivatives as a new strategy to counter act Aβ aggregation progression involved in Alzheimer disease (AD) and better understand the deep relationship between Aβ peptide and GAGs.

ADDRESSING THE MOLECULAR BASIS OF THE INTERACTION BETWEEN GLYCOSAMYNOGLYCAN, MIMETICS AND PROTEINS / D. Gaudesi ; tutor: Sandro Sonnino, supervisor: Marco Guerrini ; coordinatore: Francesco Bonomi. - : . Universita' degli Studi di Milano, 2010 Dec 09. ((23. ciclo, Anno Accademico 2010. [10.13130/gaudesi-davide_phd2010-12-09].

ADDRESSING THE MOLECULAR BASIS OF THE INTERACTION BETWEEN GLYCOSAMYNOGLYCAN, MIMETICS AND PROTEINS

D. Gaudesi
2010-12-09

Abstract

Glycosaminoglycans (GAGs) are some of the most relevant biological molecules, involved in important biological, physiological activities and also used as pharmaceutical agents. GAG research activities oriented to understand their nature, molecular population composition, characterisation, protein-GAG interaction network and putative pharmaceutical properties are essential to develop new drug with a more controlled and described activity. Recently experimental and clinical informations had increased the attention over heparan sulfate (HS)/ heparin (Hep) coagulant and not coagulant activity opening new fields of research oriented to develop new therapeutical strategy involving heparin usage. Hep mimetics/dericvatives can be extremely helpful from this perspective, due to their controlled nature, molecular features and structure, thus they can be employed as performance drugs. My Ph.D. thesis deals with statistical characterisation of commercial and not commercial pharmaceutical heparin, composition and structural characterisation of heparin mimetics and characterisation of protein-heparin interaction for drug design strategy. Thesis focus was oriented on three different subject: 1) build a library of accepted and well charaterised heparins, set up a statistical analysis based on a principal component analysis (PCA) approach to statistically define heparin molecular nature and to develop a new heparin quality control procedure. 2) 1D/2D NMR interaction studies (1H, TOCSY, NOESY, ROESY, trNOE and STD) to understand the importance of heparin antithrombin (AT) binding domain (AT-bd, the pentasaccharide β-D-N-acetylated,6-O-sulfated glucosamine -α(1->4)-D-glucuronic acid -β(1->4)-D-N-sulfated,3,6-O-sulfated glucosamine -α(1->4)-D-2-O-sulfated iduronic acid -α(1->4)-D-N-sulfated,6-O-sulfated glucosamine, also abbreviated as AGA*IA) flanking residues over AT activation on octasaccharides bearing the pentasaccharide sequence with normal or modified reducent residue in complex with AT. 3) dynamic light scattering (DLS) studies on amyloid beta 1-40 (Aβ1-40)-heparin or heparin mimetics/derivatives as a new strategy to counter act Aβ aggregation progression involved in Alzheimer disease (AD) and better understand the deep relationship between Aβ peptide and GAGs.
SONNINO, SANDRO
BONOMI, FRANCESCO
GAGs ; heparin ; heparin mimetics ; PCA ; NMR ; AT ; AT-bd ; DLS ; Alzheimer disease ; Aβ
Settore BIO/10 - Biochimica
ADDRESSING THE MOLECULAR BASIS OF THE INTERACTION BETWEEN GLYCOSAMYNOGLYCAN, MIMETICS AND PROTEINS / D. Gaudesi ; tutor: Sandro Sonnino, supervisor: Marco Guerrini ; coordinatore: Francesco Bonomi. - : . Universita' degli Studi di Milano, 2010 Dec 09. ((23. ciclo, Anno Accademico 2010. [10.13130/gaudesi-davide_phd2010-12-09].
Doctoral Thesis
File in questo prodotto:
File Dimensione Formato  
phd_unimi_R07803.pdf

embargo fino al 01/01/2011

46.99 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/148876
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact